FY14Q2 Earnings Release


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 19, 2013
 _____________________________ 
Medtronic, Inc.
(Exact name of Registrant as Specified in its Charter)
  _____________________________ 
 
Minnesota
 
1-7707
 
41-0793183
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
710 Medtronic Parkway Minneapolis, Minnesota
 
55432
(Address of principal executive offices)
 
(Zip Code)
(Registrant’s telephone number, including area code): (763) 514-4000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 _____________________________ 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 2.02.
Results of Operations and Financial Condition
On November 19, 2013, Medtronic, Inc. issued a press release announcing its second quarter 2014 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
 
Item 9.01.
Exhibits.
(d) Exhibit 99.1    Press release of Medtronic, Inc. dated November 19, 2013.







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MEDTRONIC, INC.
 
 
 
 
 
 
 
 
By
 
/s/ Gary L. Ellis
Date: November 19, 2013
 
 
 
 
 
Gary L. Ellis
 
 
 
 
 
 
Senior Vice President and Chief Financial Officer









EXHIBIT INDEX
Medtronic, Inc.
Form 8-K Current Report
 
Exhibit Number
  
Description
 
 
99.1
  
Press release dated November 19, 2013